This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DS Healthcare Group Reports First Quarter 2013 Revenues Up 100% To $3,965,000

Pompano Beach, May 16, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group Inc. (NASDAQ:DSKX), a leading developer of personal care products, today announced results for its 2013 first quarter, ended March 31, 2013.

Net revenues for the quarter grew to $3,965,000, a 100 percent increase over revenues of $1,983,982 in the first quarter of 2012. Revenue growth was primarily driven by increased sales and continued demand for the company's products, supported by its extensive marketing and sales efforts to expand the distributor and customer base.

Gross profits increased by 69 percent to $1,774,684 in the first quarter, as compared to $1,050,320 in the first quarter of fiscal 2012.

Net loss increased by five percent to $(457,993) or $(0.04) per basic and diluted share in the first quarter of 2013, as compared with a net loss of $(440,337) or $(0.04) per basic and diluted share in the first quarter of 2012. .

The company reported total current assets of $6,165,301 and total shareholders' equity of $3,850,009 for the period ended March 31, 2013.

"This was a very strong quarter for us. We invested in building our distribution network and brand awareness. These investments produced results within the quarter and, more important, these are long-term investments that we believe will continue to support sales growth for the balance of 2103 and beyond. Customer enthusiasm for our products is strong, and we believe it will continue to translate into higher sales," stated DS Healthcare President and CEO Daniel Khesin.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development of biotechnology for topical and nutritional therapies. It markets through online and specialty retailers, distributors, cosmetics wholesalers, and salons. Its brands include DS Laboratories (, Sigma Skin (, Polaris Research Laboratories ( and The Pure Guild (

Forward-looking statements

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 0.21%
FB $116.73 0.00%
GOOG $691.02 0.00%
TSLA $247.54 -0.07%
YHOO $36.59 0.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs